Search companies or stocks...
Savara (SVRA) is the most overvalued stock in the Healthcare sector with an estimated 99.7% downside, followed by Spyre Therapeutics, (SYRE) at 99.7%, Revolution Medicines, (RVMD) at 99.3%, and Centessa Pharmaceuticals (CNTA) at 98.8%.
Updated todayBased on intrinsic value modelsSector: Healthcare
Page snapshot: 17 July 2026, 9:59 pm
View full analysis in the screener → · All most overvalued sectors →
Before you trade on valuation alone
Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.
They are Healthcare companies where the share price sits furthest above modeled intrinsic (fair) value—often expressed as the largest headline downside versus the current quote.
This screen ranks names by headline downside on our snapshot; it is not a recommendation and models can disagree—always validate on the company page.
We combine a live most-overvalued feed for this sector with price and market-cap context. Downside is expressed versus modeled intrinsic value; fair value and rankings can change as inputs move.
Rankings can shift intraday as prices move. Use the stock screener for custom filters beyond this sector leaderboard.
Answers about the most overvalued healthcare names, intrinsic value, and how often this list refreshes.
MostOvervalued healthcare stocks are Healthcare companies whose market prices sit above modeled intrinsic (fair) value—often shown as positive downside versus price. The gap is model-dependent and can change quickly; it is a screen, not a recommendation.
We pull a live Healthcare mostOvervalued list ranked by headline downside, then show price, intrinsic value, market cap, and country context. Use column sorts on the table and company pages to validate fundamentals before acting.
Not automatically. A discount to a model can reflect risk, cyclical pressure, or stale inputs as easily as opportunity. Always review financials, liquidity, and your goals; seek licensed advice for personal decisions.
Common drivers include sentiment, earnings revisions, sector rotation, rates, and idiosyncratic news. Models may also disagree—treat upside as one input alongside quality and risk.
This page is rebuilt on a schedule (typically hourly) from our servers. Prices and model inputs can move intraday—open a company page for the latest detail.
